Intimation of Closure of Trading Window in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd has informed BSE that its trading window will remain closed from Wednesday, October 1, 2025, until 48 hours after the announcement of unaudited financial results (standalone and consolidated) for the quarter and half-year ending September 30, 2025. During this period, designated persons and their immediate relatives are prohibited from trading in the company's equity shares. PANs of designated persons will also be frozen at the NSDL depository portal as per SEBI circulars. The board meeting date to approve the Q2/H1 FY26 results will be communicated separately. This is a routine quarterly compliance filing under SEBI's insider trading regulations.
This is a standard regulatory disclosure with no direct impact on shareholders or stock price. It signals that Q2 and H1 FY26 results are upcoming, which could be a near-term catalyst for the stock.